Learning outcomes
By the end of this lesson you should be able to: define delusion, hallucination and formal thought disorder and recognise each in a patient's account; describe the positive, negative, disorganisation, cognitive and affective symptom groups of schizophrenia and the first-rank symptoms of Schneider; distinguish schizophrenia from schizoaffective disorder, delusional disorder, brief psychotic disorder, psychotic depression and mania, substance-induced and medically induced psychosis, and delirium; outline the natural history of the disorder, its prognosis and its excess mortality; and describe the first-line drug treatment, its principal side effects including neuroleptic malignant syndrome, the role of clozapine, and the psychosocial interventions that reduce relapse.
Prerequisites
Lesson 6 (Aetiology and the biopsychosocial model) for the genetic and dopaminergic background, and Lesson 5 (Classification and assessment) for the history and mental status examination that produce these descriptions.
The big idea
Schizophrenia is best understood not as the presence of bizarre symptoms but as a narrowing of the field of consciousness — a loss of the automatic filtering that lets most people experience only what is relevant. Bleuler described it as a fragmentation of the normally connected functions of personality. That model explains why the symptoms seem so disparate: the patient cannot distinguish the important from the trivial, cannot hold a train of thought together, cannot separate their own mental activity from external events. It also explains why the most disabling features are the negative ones, because the capacity to initiate and sustain goal-directed action is itself impaired.
The phenomena of psychosis
| Phenomenon | Definition | Typical description by a patient | Points to note on questioning |
|---|---|---|---|
| Delusion | A fixed false belief, held with conviction despite evidence and despite the absence of any shared cultural or religious explanation for it | 'The television company are broadcasting my thoughts to the neighbours.' | Distinguish from overvalued ideas, obsessions and cultural beliefs: delusions are unshakable by evidence, and obsessions are recognised by the patient as unreasonable |
| Delusional perception | A Schneider first-rank symptom: a genuine perception is invested with a delusional meaning | 'When the traffic light turned green I knew I was chosen.' | First-rank symptoms are strongly associated with schizophrenia but are not pathognomonic and occur in affective and organic psychoses too |
| Hallucination | A perception without an external stimulus, experienced with the quality of a real perception | 'Two men argue about me in the wall; I hear them every evening.' | Auditory third-person voices, a running commentary and voices arguing are most typical; pseudohallucinations are recognised as unreal and arise in subjective inner space |
| Formal thought disorder | A disorder of the form and linkage of thought, inferred from speech | 'I was walking down the, and then the paint, well the colour reminded me of the hospital and the nurses are in the... the plants.' | Listen for derailment (slipping off the point), tangentiality (answering obliquely), loosening of associations, blocking, neologisms and clang associations |
| Passivity experiences | Made feelings, made impulses and made acts: experiences are imposed by an external agency | 'They move my arm and I have to hit him — it is not my act.' | Ask about the boundary between self and other; this is one of the most diagnostically specific of the first-rank symptoms |
| Thought insertion, withdrawal and broadcasting | One's own thoughts are put in by others, taken out, or shared with others | 'They take my thoughts out and read them on the air.' | Distinguish from thought echo, which is hearing one's own thoughts repeated aloud — another first-rank symptom |
| Disorganisation | Disorganised speech, behaviour and affect, breaking the coherence of action | A patient dressing in the corridor in an outdoor coat in August | Look for incoherence at the level of behaviour as well as speech |
| Catatonia | A syndrome of motor abnormality — immobility, mutism, posturing, waxy flexibility, negativism, echolalia and echopraxia | A patient holding an arm raised for hours after being assisted into that position | Catatonia is a psychiatric emergency; it is frequently missed and can be lethal, and it is no longer confined to schizophrenia |
NoteSchneider's first-rank symptoms are: audible thoughts (thought echo), voices arguing, voices commenting in the third person, somatic passivity, made affect, made impulses, made acts, thought insertion, thought withdrawal, thought broadcasting, and delusional perception. Their value is real but bounded: they occur in mania and psychotic depression too, their absence never excludes schizophrenia, and their insensitivity has been repeatedly criticised. They are a pointer, not a rule.
The symptom groups
The five groups are conventionally remembered as the five As: Affect (flattened), Alogia (poverty of speech), Avolition (loss of drive), Asociality, and Anhedonia (loss of pleasure). The division between positive and negative symptoms is the most clinically consequential, because positive symptoms usually respond to antipsychotics and negative symptoms usually do not.
| Group | Contents | Response to antipsychotic medication | Relevance to function |
|---|---|---|---|
| Positive | Delusions, hallucinations, thought disorder, bizarre behaviour | Usually substantial | Highly distressing but often episodic; medication substantially reduces relapse |
| Negative | Affective flattening, alogia, avolition, apathy, asociality, anhedonia | Poor to minimal — and antipsychotics can worsen them | The strongest predictor of long-term social disability, and the least responsive to treatment |
| Cognitive | Impaired attention, working memory, executive function and processing speed; social cognition deficits | Not reliably improved | Determines employability and independent living more than any other domain |
| Disorganisation | Incoherence, disorganised behaviour, inappropriate affect | Partially responsive | Sensitive to poor adherence |
| Affective | Depression, anxiety, hopelessness, suicidal ideation | Antidepressants and psychological therapy help | Depression is common and is a strong predictor of suicide in schizophrenia |
Watch outDo not mistake antipsychotic-induced bradykinesia and affective flattening for negative symptoms. Antipsychotics produce a state indistinguishable from parkinsonism, and bromocriptine, benztropine and dose reduction are all reasonable responses. Similarly, akathisia — a distressing inner restlessness with pacing and an inability to sit still — is a side effect that is frequently misread as agitation and misread as a deterioration of the illness requiring more of the same drug.
Differential diagnosis of psychosis
| Diagnosis | Discriminating feature | Duration or course | What to ask or do |
|---|---|---|---|
| Schizophrenia | Characteristic symptoms from more than one domain, with declining function | At least one month of active symptoms and six months of continuous disturbance in DSM-5; ICD-10 requires one month of active symptoms | Lifetime history of functioning; pre-admission work or study record |
| Schizoaffective disorder | A mood episode runs concurrently with psychotic symptoms AND for a substantial part of the total illness, with psychosis also present in the absence of mood disturbance for at least two weeks | Longitudinal | Construct the timeline: were the delusions present when the mood was well? |
| Delusional disorder | One or more non-bizarre encapsulated delusions without other psychotic features, and function is otherwise relatively preserved | At least three months (one month in ICD-10) | Ask what makes the belief fixed and whether anything else has changed |
| Brief psychotic disorder | Sudden onset of psychosis after a stressor, with complete return to premorbid function | Under one month, typically days | Ask how abruptly it began and whether the stressor was identifiable |
| Schizophreniform disorder | Schizophrenia-like presentation not yet of sufficient duration | One to six months | Follow-up over time before diagnosing |
| Schizotypal disorder | Odd, eccentric beliefs and behaviour with perceptual disturbance but no sustained delusions or hallucinations | Chronic, lifelong | Developmental history from family; this lies in the spectrum rather than being equivalent to it |
| Psychotic depression and mania with psychotic features | Mood-congruent delusions of guilt, worthlessness, poverty or nihilism in depression; grandiose delusions in mania | Episodic, tracking the mood | Screen for a past history of elevated or irritable mood, decreased sleep and increased activity — the bipolar question |
| Substance-induced psychosis | Temporal relation to use or withdrawal, and persisting after abstinence | Clears within days to a month of abstinence (a year for cannabis per DSM-5) | Quantify substance use; urine screen; always ask about amphetamines, cocaine, high-potency cannabis, hallucinogens, anabolic steroids and novelty drugs |
| Psychosis due to a medical condition | Hallucinations of smell or taste, visual hallucinations, focal neurology, disorientation | Symptom onset tracks the medical illness | Thyroid function, B12, calcium, glucose, cortisol, MRI, EEG for suspected epilepsy and autoimmune encephalitis |
| Delirium | Acute onset with impaired attention and a fluctuating level of consciousness, with visual hallucinations and disorientation | Hours to days, reversible | Always the first exclusion in acute psychosis in an older or medically unwell patient |
Watch outAlways screen for bipolar disorder before prescribing an antidepressant for a depressed patient with psychotic features. Unopposed antidepressants can precipitate mania and can worsen the long-term course, so the question 'have you ever had several days when you needed much less sleep than usual and felt unusually energetic?' is as important as the depression rating.
Course, prognosis and mortality
Onset is typically late adolescence or the third decade in men and somewhat later in women; onset after forty is unusual and demands a search for an organic cause. A prodrome of subtle social withdrawal, unusual thinking, declining function and perceptual hypersensitivity often precedes the first episode by months or years, and an acute first presentation usually separates a recognisable pre-morbid from the episode itself.
| Phase | Duration | Clinical feature | Implication |
|---|---|---|---|
| Prodrome | Weeks to years | Declining function, social withdrawal, suspiciousness, perceptual hypersensitivity | The window in which early intervention carries the best evidence, so first-episode services have developed precisely here |
| Acute episode | Weeks to months | Positive symptoms dominating; often precipitated by stress, cannabis use or non-adherence | Urgent treatment; risk of suicide is highest in this phase and the first years after it |
| Stabilisation | Months | Resolution of positive symptoms; negative and cognitive deficits emerge as the acute noise clears | Intensive psychosocial rehabilitation and careful re-titration |
| Long-term | Years to lifetime | Variable: roughly a third have a good outcome, a third episodic, a third chronic and disabling | Relapse prevention is the central task, because each relapse costs function that may not return |
NoteAdherence is the single strongest modifiable determinant of relapse: stopping antipsychotic medication raises relapse risk roughly five-fold, and the risk is concentrated in the first months after discontinuation. This is the rationale for long-acting injectable antipsychotics, which pragmatically solve the problem of missed doses, and for psychoeducation framed as protection rather than coercion.
Excess mortality in schizophrenia is serious and under-recognised: life expectancy is reduced by roughly ten to twenty years, driven by cardiovascular disease, diabetes, smoking, and by suicide, which carries about a tenfold increase in risk with around five to ten percent of patients dying by suicide — concentrated in the first years, in young men, and after discharge. The gap is partly a disease factor, partly a consequence of antipsychotic metabolic side effects, and partly the consequence of physical health care being delivered less well to psychiatric patients.
Treatment
Antipsychotic medication is the core of treatment, and all licensed antipsychotics are dopamine D2 antagonists, with the second-generation agents also blocking 5-HT2A receptors. The first-line choice is made on side-effect profile, previous response, route and patient preference, not on differences in efficacy between agents that are real but modest.
| Adverse effect | Mechanism and timing | Management |
|---|---|---|
| Acute dystonia | D2 blockade, within hours or days — oculogyric crisis, torticollis, trismus | Procyclidine or benztropine intramuscularly; it resolves within minutes and is not a reason to abandon the drug on its own |
| Parkinsonism | Weeks to months — bradykinesia, rigidity, tremor, mask-like face | Reduce the dose; add an anticholinergic short-term; consider switching; do not confuse with negative symptoms |
| Akathisia | Onset within weeks — inner restlessness with an inability to sit still | Frequently misread as agitation; reduce the dose, switch, or add propranolol; high suicide risk if untreated |
| Tardive dyskinesia | Years of exposure, in a minority — involuntary oral-buccal-lingual movements | Often irreversible; stop or switch if identified early; tetrabenazine, valbenazine and deutetrabenazine are options; document at baseline and monitor |
| Hyperprolactinaemia | D2 blockade of the tuberoinfundibular pathway — amenorrhoea, galactorrhoea, sexual dysfunction, infertility, osteoporosis | Risperidone and typical antipsychotics are the worst offenders; switch to a prolactin-sparing agent such as aripiprazole or quetiapine |
| Metabolic effects | Second-generation agents, especially clozapine and olanzapine — weight gain, dyslipidaemia, insulin resistance | Weight, glucose, lipids and blood pressure at baseline, three months and annually; dietetic input |
| Neuroleptic malignant syndrome | Idiosyncratic, in the first weeks — fever, severe rigidity, autonomic instability, altered consciousness, and raised creatinine kinase | Stop the antipsychotic immediately; give supportive care, fluids, dantrolene or bromocriptine; admission and CK monitoring; mortality is low but real |
| Clozapine-specific | Agranulocytosis (up to about one percent), myocarditis, seizures, hypersalivation, severe constipation | Mandatory haematological monitoring by a registry; stop immediately and obtain an urgent full blood count if fever or sore throat occurs; check troponin if myocarditis suspected |
Watch outClozapine is the treatment of choice for treatment-resistant schizophrenia — conventionally, two adequate trials of different antipsychotics at adequate dose and duration — and it remains markedly under-used because of monitoring requirements. Under-treatment is a far greater harm to patients than the monitoring burden: it outperforms other antipsychotics on suicide, hospitalisation and global outcome, and it is the recommended agent in patients with persistent suicidality.
Psychosocial treatment is not an optional extra. Cognitive behavioural therapy for psychosis (CBTp) targets the belief system around delusions and hallucinations and reduces distress and relapse. Family intervention reduces high expressed emotion and is among the best-evidenced psychosocial interventions available. Psychoeducation, adherence therapy, supported employment, social skills training, cognitive remediation and first-episode early intervention services all have evidence, and cognitive behavioural case management reduces readmission. Recovery-oriented work with the patient's own goals is the frame in which all of it is delivered.
Watch outCompulsory treatment is a legal decision under mental health legislation, not a clinical shorthand for 'the patient disagrees'. It requires that the patient has a mental disorder of a nature or degree warranting detention, that it is necessary for the patient's health, safety or the protection of others, and that no less restrictive alternative is available — and it must be reviewed by an independent body. Capacity, the patient's own wishes and an advance statement all form part of the record, and antipsychotics used as sedation rather than treatment are a recognised abuse.
Common mistakes
Watch outTalking about 'schizophrenics' and treating them as violent. People with schizophrenia are far more likely to be the victims of crime than its perpetrators, and population-level violence is overwhelmingly attributable to substance misuse, not to psychosis. Using a diagnosis as a noun about a person, and predicting violence from it, are the two most damaging stigmatising errors available in this subject.
Watch outReading reduced emotional expression as reduced feeling. As established in Lesson 1, flattened affect is a negative symptom and a parkinsonian side effect; patients commonly report intense feeling that they cannot express. Under-recognised depression in schizophrenia is one of the commonest causes of preventable suicide in the disorder.
Watch outAccepting a single diagnosis of schizophrenia at first presentation without a substance and medical workup. Amphetamine psychosis, steroid psychosis, thyroid disease, B12 deficiency, hypercalcaemia, autoimmune encephalitis and delirium all mimic it, and each has a specific treatment that the diagnosis would obscure.
Check your understanding
A patient tells you that when she looks at the clock she knows the time was put there by the news channel as a message to her, and that twice a week two voices in the room discuss her behaviour. Classify these phenomena.
A man with schizophrenia on risperidone reports loss of libido and amenorrhoea, and new-onset visual disturbance. Which mechanisms are involved?
Which combination of findings distinguishes neuroleptic malignant syndrome from akathisia or from a relapse of psychosis?
Summary and next
Psychosis is a syndrome defined by delusions, hallucinations and formal thought disorder, occurring across many diagnoses. Schizophrenia is diagnosed by a characteristic grouping across positive, negative, disorganisation, cognitive and affective domains with a decline in function over at least six months, and the differential is wide — affective psychoses, substance-induced psychosis, delirium and medical causes must all be excluded. Antipsychotics reduce positive symptoms and relapse; negative and cognitive deficits drive long-term disability; and clozapine is the agent of choice for treatment resistance.
Next: bipolar disorder. You will see how the same psychotic phenomena occur in mood disorder, and how the diagnosis rests on longitudinal history rather than on a single episode.
Multiple choice
Which of the following is a Schneider first-rank symptom?
Which statement about negative symptoms in schizophrenia is correct?
A patient has a three-month history of somatic passivity and auditory hallucinations, alongside a persistent low mood with anhedonia and early morning waking that began one month after the psychosis and persists. Which diagnosis fits best?
Which set of findings most strongly suggests neuroleptic malignant syndrome rather than akathisia?
Which statement about clozapine is correct?